Belgium· BE-AMP-SAM528675-00

Lokelma 10 g

A sodium zirconium cyclosilicate product containing sodium zirconium cyclosilicate, registered in Belgium by AstraZeneca. The same ATC class is registered in 14 of our 19 countries.

ATC V03AE10

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about sodium zirconium cyclosilicateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Sodium zirconium cyclosilicate is registered in 14 of 19 countries.

Countries holding a registration under ATC V03AE10 (sodium zirconium cyclosilicate), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
8 of them publish a price we can compare per daily dose

Search sodium zirconium cyclosilicate products by name

Sodium zirconium cyclosilicate · ATC V03AE10

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sodium zirconium cyclosilicate costs, country by country.

Normalised to the WHO defined daily dose (7.5 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Sodium zirconium cyclosilicate · price per daily dose (7.5 g)

USD · FX 28 Sept 2026

FI Finland$1.86

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Sodium Zirconium Cyclosilicate
Manufacturer: AstraZeneca
Country: Belgium (BE)
ATC code: V03AE10
ATC class: Sodium zirconium cyclosilicate
Defined daily dose: 7.5 g, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 11

5 priced

be_apb
4235669
EUR 323.35
be_apb
4843066
EUR 323.35
be_apb
4872958
EUR 323.35
be_apb
4920104
EUR 323.35
be_apb
4946000
EUR 323.35
be_apb
4235677
be_apb
7731532
be_apb
7740780
be_apb
7742745
be_apb
7747330
be_apb
7748460

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

20 interactions on record for sodium zirconium cyclosilicate.

Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check sodium zirconium cyclosilicate against other medicines How interaction checks work

Sodium zirconium cyclosilicate · interactions on record

20 records

20 moderate

Most severe, free to view

FurosemideC03CA01moderate
AtorvastatinC10AA05moderate
KetoconazoleH02CA03moderate
KetoconazoleJ02AB02moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sodium zirconium cyclosilicate in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium zirconium cyclosilicate products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

Iceland · Lokelma
Liechtenstein · Lokelma
Norway · Lokelma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/4dd82fcc-01aa-4be1-849f-0d167ef8a682
GET /v1/drugs/4dd82fcc-01aa-4be1-849f-0d167ef8a682?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for oral suspension",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Lokelma 10 g",
  "name_fr": "Lokelma 10 g",
  "name_nl": "Lokelma 10 g",
  "amp_code": "SAM528675-00",
  "strengths": [
    "10.0000",
    "10.0000"
  ],
  "pack_count": 10,
  "substances": [
    "Sodium Zirconium Cyclosilicate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Sodium Zirconium Cyclosilicate",
  "authorisation_numbers": [
    "EU/1/17/1173/003",
    "EU/1/17/1173/004",
    "EU/1/17/1173/012",
    "EU/1/17/1173/011",
    "EU/1/17/1173/006",
    "EU/1/17/1173/010"
  ]
}

API reference MCP server Plans

See everything about sodium zirconium cyclosilicate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console